Phase I studies of drug combinations

MeSH terms

• Angiogenesis Inhibitors / administration & dosage
• Antimetabolites, Antineoplastic / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Capecitabine
• Clinical Trials, Phase I as Topic*
• Deoxycytidine / administration & dosage
• Deoxycytidine / analogs & derivatives
• Drug Administration Schedule
• Drug Interactions
• Evidence-Based Medicine
• Fluorouracil / administration & dosage
• Fluorouracil / analogs & derivatives
• Humans
• Intracellular Signaling Peptides and Proteins / antagonists & inhibitors
• Intracellular Signaling Peptides and Proteins / metabolism
• Maximum Tolerated Dose
• Neoplasms / drug therapy*
• Neoplasms / enzymology
• Neoplasms / pathology
• Protein Kinase Inhibitors / administration & dosage
• Protein Serine-Threonine Kinases / antagonists & inhibitors
• Protein Serine-Threonine Kinases / metabolism
• Sirolimus / administration & dosage
• Sirolimus / analogs & derivatives
• TOR Serine-Threonine Kinases
• Treatment Outcome